Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-010916
Filing Date
2022-10-31
Accepted
2022-10-31 17:21:52
Documents
1
Period of Report
2022-10-27

Document Format Files

Seq Description Document Type Size
1 form4-10312022_021043.html 4  
1 form4-10312022_021043.xml 4 10757
  Complete submission text file 0001415889-22-010916.txt   12184
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Issuer) CIK: 0000842023 (see all company filings)

EIN.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address
VESSEY RUPERT (Reporting) CIK: 0001677618 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-17272 | Film No.: 221347195